Genetic studies have shown that gain-of-function mutations of the PCSK9 gene caused hypercholesterolemia (5), whereas loss-of-function mutations in PCSK9 resulted in hypocholesterolemia and reduced risk of cardiovascular disease (6, 7). This evidence concerns the gene PCSK9 and cardiovascular disorder.